Summary
The pharmacokinetics of norethisterone have been studied in 8 women during and one month after treatment with rifampicin (450–600 mg/day). Rifampicin caused a significant reduction in the A. U. C. of a single dose of 1 mg norethisterone from 37.8±13.1 to 21.9±5.9 ng/ml X h (p<0.01). The plasma norethisterone half life (β-phase) was also reduced from 6.2±1.7 to 3.2±1.0 h (p<0.0025). In one additional woman on long term oral contraceptive therapy the 12 hour plasma norethisterone concentration was reduced by rifampicin from 12.3 ng/ml to 2.3 ng/ml. Rifampicin caused a significant increase in antipyrine clearance, 6β-hydroxycortisol excretion and plasma gamma-glutamyltranspeptidase activity but there were no significant correlations between changes in these indices of liver microsomal enzyme induction. There was a significant correlation between the percentage increase in antipyrine clearance and the percentage decrease in norethisterone A. U. C. during rifampicin. The changes in norethisterone pharmacokinetics during rifampicin therapy are compatible with the known enzyme inducing effect of rifampicin.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Reimers, D., Jezek, A.: Rifampicin und andere Antituberkulostatika bei gleichzeitiger oraler Kontrazeption. Prax. Pneumol.25, 255–262 (1971)
Nocke-Finck, L., Breuer, H., Reimers, D.: Wirkung von Rifampicin auf den Menstruationszyklus und die Östrogenausscheidung bei Einnahme oraler Kontrazeptiva. Dtsch. med. Wochenschr.98, 1521–1523 (1973)
Hirsch, A.: Pilules endormies. Nouv. Presse méd.2, 2957 (1973)
Kropp, R.: Rifampicin und Ovulationshemmer. Prax. Pneumol.28, 270–272 (1974)
Hirsch, A., Tillement, J. P., Chretien, J.: Effets contrariants de la rifampicine sur les contraceptifs oraux: a propos de trois grossesses non desirees chez trois malades. Rev. Fr. Mal. Respir.3, 174–182 (1975)
Piquet, B., Muglioni, J. F., Chaline, G.: Contraception orale et rifampicine. Nouv. Presse méd.4, 115–117 (1975)
Lafaix, C., Cadoz, M., Richard, A., Patouillard, P.: L'effet “antipilule” de la rifampicine. Med. Hyg.1181, 181–182 (1976)
Skolnick, J. L., Stoler, B. S., Katz, D. G., Anderson, W. H.: Rifampicin, oral contraceptives and pregnancy. J. Amer. med. Assoc.236, 1382 (1976)
Bessot, J. C., Petitjean, R., Vandevenne, A., Rempp, M., Burghard, G.: Interference de la rifampicine sur les contraceptives oraux. J. Med. Strasbourg8, 131–134 (1977)
Bolt, H. M., Kappus, H., Bolt, M.: The effect of rifampicin treatment on the metabolism of oestradiol and 17-ethinyloestradiol by human liver microsomes. Europ. J. clin. Pharmacol.8, 301–307 (1975)
Back, D. J., Breckenridge, A. M., Crawford, F. E., MacIver, M., Orme, M. L'E., Park, K., Rowe, P. H., Smith, E.: The pharmacokinetics of norethindrone in women. 1. Radioimmunoassay and concentrations during multiple dosing. Clin. Pharmacol. Ther.24, 439–447 (1978)
Riegelman, S., Loo, J. C. K., Rowland, M.: Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment. J. Pharm. Sci.57, 117–123 (1968)
Back, D. J., Breckenridge, A. M., Crawford, F. E., MacIver, M., Orme, M. L'E., Rowe, P. H., Smith, E.: Pharmacokinetics of norethindrone in women. 2. Single dose studies. Clin. Pharmacol. Ther.24, 447–454 (1978)
Chang, R. L., Wood, A. W., Dixon, W. R., Conney, A. H., Anderson, K. E., Eiseman, J., Alvares, A. P.: Antipyrine: radioimuunoassay in plasma and saliva following administration of a high dose and a low dose. Clin. Pharmacol. Ther.20, 219–226 (1976)
Branch, R. A., Shand, D. G., Wilkinson, G. R., Nies, A. S.: Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. J. Clin. Invest.53, 1101–1107 (1974)
Park, B. K.: A direct radioimmunoassay for 6β-hydroxycortisol in human urine. J. Steroid Biochem.9, 963–966 (1978)
Silber, R., Porter, C. C.: The determination of 17–21 dihydroxyketosteroids in urine and plasma. J. Biol. Chem.210, 923–932 (1954)
Szasz, G.: A kinetic photometric method for serum-glutamyltranspeptidase. Clin. Chem.15, 124–136 (1969)
Bolt, H. M., Bolt, M., Kappus, H.: Interaction of rifampicin treatment with pharmacokinetics and metabolism of ethinyloestradiol in man. Acta Endocrinol.85, 189–197 (1977)
Zilly, W., Breimer, D. D., Richter, E.: Induction of drug metabolism in man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance. Europ. J. clin. Pharmacol.9, 219–228 (1975)
Zilly, W., Breimer, D. D., Richter, E.: Stimulation of drug metabolism by rifampicin in patients with cirrhosis or cholestasis measured by increased hexobarbital and tolbutamide clearance. Europ. J. clin. Pharmacol.11, 287–293 (1977)
O'Reilly, R. A.: Interaction of chronic daily Warfarin therapy and rifampicin. Ann. int. med.83, 506–508 (1975)
Miguet, J. P., Mavier, P., Soussy, C. J., Dhumaraux, D.: Induction of hepatic microsomal enzymes after brief administration of rifampicin in man. Gastroenterology72, 924–926 (1977)
Ohnhaus, E.: A comparison of three different enzyme inducing agents and their influence on plasma lipids in man. Brit. J. Clin. Pharmacol.4, 398P (1977)
Back, D. J., Breckenridge, A. M., Challiner, M., Crawford, F. E., Orme, M. L'E., Rowe, P. H., Smith, E.: The effect of antibiotics on the enterohepatic circulation of ethinyloestradiol and norethisterone in the rat. J. Steroid Biochem.9, 527–531 (1978)
Ohnhaus, E., Park, K.: The measurement of 6β-hydroxycortisol urinary excretion as an in vivo parameter in the assessment of the microsomal enzyme inducing capacity of three different drugs in man: antipyrine, phenobarbitone and rifampicin. Europ. J. clin. Pharmacol.15, 139–145 (1979)
Breimer, D. D., Zilly, W., Richter, E.: Influence of rifampicin on drug metabolism: differences between hexobarbital and antipyrine. Clin. Pharmacol. Ther.21, 470–481 (1977)
Vessell, E. S., Page, J. G.: Genetic control of the phenobarbital induced shortening of plasma antipyrine half lives in man. J. Clin. Invest.48, 2202–2209 (1969)
Smith, S. E., Rawlins, M. D.: Prediction of drug oxidation rates in man: lack of correlation with serum gamma-glutamyltranspeptidase and urine excretion of D-glucaric acid and 6β-hydroxycortisol. Europ. J. clin. Pharmacol.7, 71–75 (1974)
Hildebrandt, A. G., Roots, I., Speck, M., Saalfrank, K., Kewitz, H.: Evaluation of in vivo parameters of drug metabolising enzyme activity in man after administration of clemastine, phenobarbital or placebo. Europ. J. clin. Pharmacol.8, 327–336 (1975)
Kutt, H., Brennan, R., Dehejia, H., Verebely, K.: Diphenylhydantoin intoxication: A complication of isoniazid therapy. Am. Rev. Respir. Dis.101, 377–384 (1970)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Back, D.J., Breckenridge, A.M., Crawford, F. et al. The effect of rifampicin on norethisterone pharmacokinetics. Eur J Clin Pharmacol 15, 193–197 (1979). https://doi.org/10.1007/BF00563105
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00563105